Left unable to speak or walk after a malfunction, the 50-year-old feels the vulnerabilities in this technology needs to be ...

Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes.

Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the ...

DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...

Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

Heald, a digital metabolic health platform, today announced that consumers who purchase a Dexcom Stelo or Abbott Lingo continuous glucose monitor (CGM) through Heald will now receive complimentary ...

Smartwatches still can’t measure blood sugar on their own, but AI-powered CGMs are changing how glucose data is tracked and ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

Apple Watch blood sugar tracking remains unconfirmed. Here's the latest on the timeline, patents, technical challenges, and what Apple Watch can do now.

Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support. The Apple Watch can make glucose checks quicker, but it does not measure blood ...